Last: | $32.49 |
---|---|
Change Percent: | 14.89% |
Open: | $30.34 |
Close: | $32.49 |
High: | $33.15 |
Low: | $29.74 |
Volume: | 1,097,205 |
Last Trade Date Time: | 03/09/2021 04:55:45 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$32.49 | $30.34 | $32.49 | $33.15 | $29.74 | 1,097,205 | 03-09-2021 |
$28.28 | $27.95 | $28.28 | $30.32 | $26.5 | 1,291,997 | 03-08-2021 |
$26.8 | $28.22 | $26.8 | $28.24 | $23.15 | 1,339,343 | 03-05-2021 |
$25.75 | $26.03 | $25.75 | $27.5 | $23.88 | 1,576,580 | 03-04-2021 |
$26.58 | $28.08 | $26.58 | $28.66 | $26.13 | 1,054,506 | 03-03-2021 |
$28.36 | $33 | $28.36 | $33.4899 | $27.67 | 1,887,725 | 03-02-2021 |
$33.3 | $33.23 | $33.3 | $34.617 | $32.765 | 716,126 | 03-01-2021 |
$32.51 | $34 | $32.51 | $35.91 | $30.8 | 1,394,201 | 02-26-2021 |
$34.18 | $32.61 | $34.18 | $36.725 | $32.61 | 1,291,094 | 02-25-2021 |
$32.65 | $33.34 | $32.65 | $35.64 | $31.52 | 1,593,817 | 02-24-2021 |
$32.38 | $41.4 | $32.38 | $41.4099 | $31.1201 | 4,117,530 | 02-23-2021 |
$42.25 | $38.71 | $42.25 | $45.42 | $38.3002 | 2,722,690 | 02-22-2021 |
$39.12 | $37.255 | $39.12 | $39.71 | $36.54 | 1,435,905 | 02-19-2021 |
$36.95 | $32.68 | $36.95 | $38.6 | $32.38 | 1,924,920 | 02-18-2021 |
$33.8 | $33.5 | $33.8 | $34.57 | $32 | 1,337,083 | 02-17-2021 |
$33.48 | $30.92 | $33.48 | $34.7 | $29.87 | 2,226,274 | 02-16-2021 |
$30.92 | $28.23 | $30.92 | $32.2499 | $27.11 | 2,075,407 | 02-15-2021 |
$30.92 | $28.23 | $30.92 | $32.2499 | $27.11 | 2,069,651 | 02-12-2021 |
$26.04 | $26.35 | $26.04 | $27.38 | $25.21 | 801,671 | 02-11-2021 |
$26.29 | $28.58 | $26.29 | $29.59 | $25.88 | 1,311,163 | 02-10-2021 |
News, Short Squeeze, Breakout and More Instantly...
Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...
Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...
NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...